{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:00:28Z","timestamp":1772769628406,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T00:00:00Z","timestamp":1452297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T00:00:00Z","timestamp":1452297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR001062"],"award-info":[{"award-number":["TL1TR001062"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00408-016-9842-y","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T13:51:16Z","timestamp":1452347476000},"page":"315-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic Thromboembolic Pulmonary Hypertension: Experience from a Single Center in Mexico"],"prefix":"10.1007","volume":"194","author":[{"given":"Nadine","family":"Al-Naamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaudalupe","family":"Espitia H.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Velazquez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Macuil-Chazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Serrano-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo S.","family":"Vega-Barrientos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,9]]},"reference":[{"key":"9842_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccm.2006.11.009","volume":"28","author":"WR Auger","year":"2007","unstructured":"Auger WR, Kim NH, Kerr KM et al (2007) Chronic thromboembolic pulmonary hypertension. Clin Chest Med 28:255\u2013269 x","journal-title":"Clin Chest Med"},{"key":"9842_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00049312","volume":"41","author":"IM Lang","year":"2013","unstructured":"Lang IM, Pesavento R, Bonderman D et al (2013) Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 41:462\u2013468","journal-title":"Eur Respir J"},{"key":"9842_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","volume":"130","author":"IM Lang","year":"2014","unstructured":"Lang IM, Madani M (2014) Update on chronic thromboembolic pulmonary hypertension. Circulation 130:508\u2013518","journal-title":"Circulation"},{"key":"9842_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1378\/chest.81.2.151","volume":"81","author":"M Riedel","year":"1982","unstructured":"Riedel M, Stanek V, Widimsky J et al (1982) Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81:151\u2013158","journal-title":"Chest"},{"key":"9842_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1183\/09031936.00087608","volume":"33","author":"D Bonderman","year":"2009","unstructured":"Bonderman D, Wilkens H, Wakounig S et al (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 33:325\u2013331","journal-title":"Eur Respir J"},{"key":"9842_CR6","doi-asserted-by":"publisher","first-page":"e69635","DOI":"10.1371\/journal.pone.0069635","volume":"8","author":"JF Li","year":"2013","unstructured":"Li JF, Lin Y, Yang YH et al (2013) Fibrinogen Aalpha Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance. PLoS ONE 8:e69635","journal-title":"PLoS ONE"},{"key":"9842_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood-2009-03-208264","volume":"114","author":"TA Morris","year":"2009","unstructured":"Morris TA, Marsh JJ, Chiles PG et al (2009) High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 114:1929\u20131936","journal-title":"Blood"},{"key":"9842_CR8","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","volume":"62","author":"NH Kim","year":"2013","unstructured":"Kim NH, Delcroix M, Jenkins DP et al (2013) Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 62:D92\u2013D99","journal-title":"J Am Coll Cardiol"},{"key":"9842_CR9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jtcvs.2014.06.052","volume":"148","author":"AM D\u2019Armini","year":"2014","unstructured":"D\u2019Armini AM, Morsolini M, Mattiucci G et al (2014) Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 148:1005\u20131011 1012 e1\u2013e2; discussion 1011\u20131012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9842_CR10","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Galie","year":"2009","unstructured":"Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493\u20132537","journal-title":"Eur Heart J"},{"key":"9842_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, D\u2019Armini AM, Grimminger F et al (2013) Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319\u2013329","journal-title":"N Engl J Med"},{"key":"9842_CR12","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","volume":"124","author":"J Pepke-Zaba","year":"2011","unstructured":"Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124:1973\u20131981","journal-title":"Circulation"},{"key":"9842_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1513\/pats.200605-108LR","volume":"3","author":"I Lang","year":"2006","unstructured":"Lang I, Kerr K (2006) Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3:568\u2013570","journal-title":"Proc Am Thorac Soc"},{"key":"9842_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00092008","volume":"33","author":"R Condliffe","year":"2009","unstructured":"Condliffe R, Kiely DG, Gibbs JS et al (2009) Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 33:332\u2013338","journal-title":"Eur Respir J"},{"key":"9842_CR15","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.200712-1841OC","volume":"177","author":"R Condliffe","year":"2008","unstructured":"Condliffe R, Kiely DG, Gibbs JS et al (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177:1122\u20131127","journal-title":"Am J Respir Crit Care Med"},{"key":"9842_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.arbres.2014.04.011","volume":"50","author":"ML Coronel","year":"2014","unstructured":"Coronel ML, Chamorro N, Blanco I et al (2014) Medical and surgical management for chronic thromboembolic pulmonary hypertension: a single center experience. Arch Bronconeumol 50:521\u2013527","journal-title":"Arch Bronconeumol"},{"key":"9842_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1183\/09031936.00101211","volume":"40","author":"P Escribano-Subias","year":"2012","unstructured":"Escribano-Subias P, Blanco I, Lopez-Meseguer M et al (2012) Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 40:596\u2013603","journal-title":"Eur Respir J"},{"key":"9842_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11239-009-0319-1","volume":"29","author":"HL Gan","year":"2010","unstructured":"Gan HL, Zhang JQ, Bo P et al (2010) The actuarial survival analysis of the surgical and non-surgical therapy regimen for chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis 29:25\u201331","journal-title":"J Thromb Thrombolysis"},{"key":"9842_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11739-011-0610-y","volume":"8","author":"C Marini","year":"2013","unstructured":"Marini C, Formichi B, Bauleo C et al (2013) Improved survival in patients with inoperable chronic thromboembolic pulmonary hypertension. Intern Emerg Med 8:307\u2013316","journal-title":"Intern Emerg Med"},{"key":"9842_CR20","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1253\/circj.CJ-12-1391","volume":"77","author":"R Nishimura","year":"2013","unstructured":"Nishimura R, Tanabe N, Sugiura T et al (2013) Improved survival in medically treated chronic thromboembolic pulmonary hypertension. Circ J 77:2110\u20132117","journal-title":"Circ J"},{"issue":"1","key":"9842_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1076029614536604","volume":"22","author":"M Wieteska","year":"2016","unstructured":"Wieteska M, Biederman A, Kurzyna M et al (2016) Outcome of medically versus surgically treated patients with chronic thromboembolic pulmonary hypertension. Clin Appl Thromb Hemost 22(1):92\u201399","journal-title":"Clin Appl Thromb Hemost"},{"key":"9842_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","volume":"94","author":"MM Madani","year":"2012","unstructured":"Madani MM, Auger WR, Pretorius V et al (2012) Pulmonary endarterectomy: recent changes in a single institution\u2019s experience of more than 2,700 patients. Ann Thorac Surg 94:97\u2013103 discussion 103","journal-title":"Ann Thorac Surg"},{"key":"9842_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.resinv.2013.02.005","volume":"51","author":"N Tanabe","year":"2013","unstructured":"Tanabe N, Sugiura T, Tatsumi K (2013) Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Respir Investig 51:134\u2013146","journal-title":"Respir Investig"},{"key":"9842_CR24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1160\/TH03-02-0067","volume":"90","author":"D Bonderman","year":"2003","unstructured":"Bonderman D, Turecek PL, Jakowitsch J et al (2003) High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 90:372\u2013376","journal-title":"Thromb Haemost"},{"key":"9842_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1160\/TH13-02-0097","volume":"110","author":"IM Lang","year":"2013","unstructured":"Lang IM, Simonneau G, Pepke-Zaba JW et al (2013) Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemost 110:83\u201391","journal-title":"Thromb Haemost"},{"key":"9842_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1164\/rccm.200801-101OC","volume":"178","author":"AG Corsico","year":"2008","unstructured":"Corsico AG, D\u2019Armini AM, Cerveri I et al (2008) Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 178:419\u2013424","journal-title":"Am J Respir Crit Care Med"},{"key":"9842_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0003-4975(03)00828-2","volume":"76","author":"SW Jamieson","year":"2003","unstructured":"Jamieson SW, Kapelanski DP, Sakakibara N et al (2003) Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76:1457\u20131462 discussion 1462\u20131464","journal-title":"Ann Thorac Surg"},{"key":"9842_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jtcvs.2011.11.041","volume":"144","author":"M Morsolini","year":"2012","unstructured":"Morsolini M, Nicolardi S, Milanesi E et al (2012) Evolving surgical techniques for pulmonary endarterectomy according to the changing features of chronic thromboembolic pulmonary hypertension patients during 17-year single-center experience. J Thorac Cardiovasc Surg 144:100\u2013107","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9842_CR29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","volume":"167","author":"HA Ghofrani","year":"2003","unstructured":"Ghofrani HA, Schermuly RT, Rose F et al (2003) Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 167:1139\u20131141","journal-title":"Am J Respir Crit Care Med"},{"key":"9842_CR30","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1183\/09031936.00039007","volume":"30","author":"F Reichenberger","year":"2007","unstructured":"Reichenberger F, Voswinckel R, Enke B et al (2007) Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 30:922\u2013927","journal-title":"Eur Respir J"},{"key":"9842_CR31","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1378\/chest.128.4.2599","volume":"128","author":"D Bonderman","year":"2005","unstructured":"Bonderman D, Nowotny R, Skoro-Sajer N et al (2005) Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 128:2599\u20132603","journal-title":"Chest"},{"key":"9842_CR32","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","volume":"52","author":"X Jais","year":"2008","unstructured":"Jais X, D\u2019Armini AM, Jansa P et al (2008) Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 52:2127\u20132134","journal-title":"J Am Coll Cardiol"},{"key":"9842_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/MOH.0b013e328363c170","volume":"20","author":"S Ghanny","year":"2013","unstructured":"Ghanny S, Crowther M (2013) Treatment with novel oral anticoagulants: indications, efficacy and risks. Curr Opin Hematol 20:430\u2013436","journal-title":"Curr Opin Hematol"},{"key":"9842_CR34","first-page":"274","volume":"14","author":"PA Thistlethwaite","year":"2008","unstructured":"Thistlethwaite PA, Kaneko K, Madani MM et al (2008) Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 14:274\u2013282","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"9842_CR35","unstructured":"Simonneau G, Delcroix, M., Lang I et al (2013) Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results of an international prospective registry comparing operated versus non-operated patients. American Thoracic Society. Philadelphia, PA: Am J Resp Crit Care Med A5365"},{"key":"9842_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1055\/s-0029-1233316","volume":"30","author":"WR Auger","year":"2009","unstructured":"Auger WR, Fedullo PF (2009) Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med 30:471\u2013483","journal-title":"Semin Respir Crit Care Med"},{"key":"9842_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11936-010-0062-0","volume":"12","author":"LM Wittine","year":"2010","unstructured":"Wittine LM, Auger WR (2010) Chronic thromboembolic pulmonary hypertension. Curr Treat Options Cardiovasc Med 12:131\u2013141","journal-title":"Curr Treat Options Cardiovasc Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-016-9842-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9842-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9842-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:22:41Z","timestamp":1589696561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-016-9842-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,9]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9842"],"URL":"https:\/\/doi.org\/10.1007\/s00408-016-9842-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,9]]},"assertion":[{"value":"20 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr Espitia has received an unrestricted grant from Bayer de Mexico S.A. de C.V. Dr Hill has received research grant support from Actelion, Gilead, Bayer, United Therapeutics, and Reata; has served on the medical advisory board for Gilead and Bayer; and has served on the data monitoring committee for Lung LLC (Limited Liability Company). Dr Preston has received grant support from Actelion, Bayer, Gilead, and United Therapeutics; and has served as a consultant for Actelion, Bayer, Gilead, United Therapeutics, and Pfizer. All other authors have reported no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}